Skip to main content

Invivo Therapeutics Holdings Corp.

NVIVDelisted Mar 21, 2024
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001292519

Invivo Therapeutics Holdings Corp. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Feb 7, 2024; 14 institutions reported holding it in 13F filings for Q4 2023, worth $68.1K in total; no superinvestor held it.

Q4 2023 vs. Q3 2023

How the institutions holding Invivo Therapeutics Holdings Corp. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of NVIV: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders1514−1
Shares104.3K93.3K−10.9K (−10.5%)
Value$118.5K$68.1K−$50.3K (−42.5%)

New holders (1)

Institutions that held Invivo Therapeutics Holdings Corp. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to NVIV in Q4 2023
InstitutionSharesValue% of portfolio
Vima LLC2$10.00%

Sold out (2)

Institutions that held Invivo Therapeutics Holdings Corp. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of NVIV in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Renaissance Technologies LLC13,921$16.0K
Milestone Investment Advisors LLC1$2